1. A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab. Issue 1 (3rd December 2021) Authors: Sako, Masahiro; Nokihara, Hiroshi; Kondo, Kensuke; Mitsuhashi, Atsushi; Ozaki, Ryohiko; Yabuki, Yohei; Abe, Akane; Yoneda, Hiroto; Ogino, Hirokazu; Otsuka, Kenji; Uehara, Hisanori; Nishioka, Yasuhiko Journal: Thoracic cancer Issue: Volume 13:Issue 1(2022) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. (November 2018) Authors: Hanibuchi, Masaki; Kakiuchi, Soji; Atagi, Shinji; Ogushi, Fumitaka; Shimizu, Eiji; Haku, Takashi; Toyoda, Yuko; Azuma, Masahiko; Kondo, Mayo; Kawano, Hiroshi; Otsuka, Kenji; Sakaguchi, Satoshi; Nokihara, Hiroshi; Goto, Hisatsugu; Nishioka, Yasuhiko Journal: Lung cancer Issue: Volume 125(2018) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. (December 2019) Authors: Hida, Toyoaki; Velcheti, Vamsidhar; Reckamp, Karen L.; Nokihara, Hiroshi; Sachdev, Pallavi; Kubota, Tomoki; Nakada, Takuya; Dutcus, Corina E.; Ren, Min; Tamura, Tomohide Journal: Lung cancer Issue: Volume 138(2019) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Issue 10089 (1st July 2017) Authors: Hida, Toyoaki; Nokihara, Hiroshi; Kondo, Masashi; Kim, Young Hak; Azuma, Koichi; Seto, Takashi; Takiguchi, Yuichi; Nishio, Makoto; Yoshioka, Hiroshige; Imamura, Fumio; Hotta, Katsuyuki; Watanabe, Satoshi; Goto, Koichi; Satouchi, Miyako; Kozuki, Toshiyuki; Shukuya, Takehito; Nakagawa, Kazuhiko; Mi... Journal: Lancet Issue: Volume 390:Issue 10089(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations. Issue 9 (9th August 2018) Authors: Murakami, Haruyasu; Nokihara, Hiroshi; Hayashi, Hidetoshi; Seto, Takashi; Park, Keunchil; Azuma, Koichi; Tsai, Chun‐Ming; Yang, James Chih‐Hsin; Nishio, Makoto; Kim, Sang‐We; Kiura, Katsuyuki; Inoue, Akira; Takeda, Koji; Kang, Jin‐Hyoung; Nakagawa, Tomoki; Takeda, Kentaro; Akazawa, Rio; Kaneko, Y... Journal: Cancer science Issue: Volume 109:Issue 9(2018) Page Start: 2852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy. Issue 3 (September 2015) Authors: Kanda, Shintaro; Horinouchi, Hidehito; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Kubota, Kaoru; Tamura, Tomohide; Ohe, Yuichiro Journal: Lung cancer Issue: Volume 89:Issue 3(2015:Sep.) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin in Japanese Patients With Locally Advanced Nonsquamous Non–Small Cell Lung Cancer: A Post Hoc Analysis of Survival and Recurrent Sites. (April 2016) Authors: Niho, Seiji; Nokihara, Hiroshi; Nihei, Keiji; Akimoto, Tetsuo; Sumi, Minako; Ito, Yoshinori; Yoh, Kiyotaka; Goto, Koichi; Ohmatsu, Hironobu; Horinouchi, Hidehito; Yamamoto, Noboru; Sekine, Ikuo; Kubota, Kaoru; Ohe, Yuichiro; Tamura, Tomohide Journal: American journal of clinical oncology Issue: Volume 39:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer. Issue 5 (26th April 2017) Authors: Hida, Toyoaki; Nishio, Makoto; Nogami, Naoyuki; Ohe, Yuichiro; Nokihara, Hiroshi; Sakai, Hiroshi; Satouchi, Miyako; Nakagawa, Kazuhiko; Takenoyama, Mitsuhiro; Isobe, Hiroshi; Fujita, Shiro; Tanaka, Hiroshi; Minato, Koichi; Takahashi, Toshiaki; Maemondo, Makoto; Takeda, Koji; Saka, Hideo; Goto, Ko... Journal: Cancer science Issue: Volume 108:Issue 5(2017) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease. Issue 21 (15th September 2022) Authors: Otsuka, Kenji; Nokihara, Hiroshi; Mitsuhashi, Atsushi; Ozaki, Ryohiko; Yabuki, Yohei; Yoneda, Hiroto; Ogino, Hirokazu; Nishioka, Yasuhiko Journal: Thoracic cancer Issue: Volume 13:Issue 21(2022) Page Start: 2978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗